|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||5.53 / 36.14|
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ("Exact" or the "Company") (Nasdaq: EXAS).
Apple CEO says fund will boost advanced manufacturing in U.S.
A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.
Aetna now offers commercial coverage of Exact Sciences' Cologuard test.
Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.
Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.
AACR abstract highlights methylation markers capable of detecting all types of lung cancer with more than 90% sensitivity and specificity
Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.
Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.
Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.
Cologuard offers health plans an opportunity to increase screening & improve quality ratings
Biotech shares have gained from takeovers in that sector.
- Preliminary revenues between $99.0 million and $99.5 million for 2016, a year-over-year increase of 150 percent;
Cologuard Covered for 70 Percent of Addressable Population
Members of Fifth Largest Commercial Insurer will have Access to Non-Invasive Colon Cancer Screening Test and Compliance Service
Respected diagnostics industry expert will help lead efforts to capitalize on market opportunity for Cologuard